Welcome

This study focuses on better understanding how prostate cancer impacts Black men of African and Caribbean ancestry, as well as men of mixed ethnic backgrounds. These groups have historically been underrepresented in research, despite facing higher risks and more aggressive forms of the disease.

Our goal is to make sure their voices are heard, their experiences are acknowledged, and their needs are reflected in healthcare services, policies, and research.

On this page, you’ll find detailed information about the study, its purpose, who can participate, and how the results will help improve care for these communities. You’ll also learn about the team behind the project, our international partners, and how to get involved.

Whether you’re taking part in the study, supporting someone who is, or just want to learn more, we’re glad you’re here.

Black men have a much higher risk of developing prostate cancer, with 1 in 4 being affected—twice the risk of White men. They are also more likely to be diagnosed at a younger age and with more aggressive forms of the disease.

These groups are often underrepresented prostate cancer research, so this study aims to make sure their experiences are better understood and reflected in healthcare and policies.

For men of mixed ethnic ancestry living, the study also wants to explore how their mixed heritage might affect their prostate cancer risk and outcomes—an area that hasn’t been studied enough.

The Diversity in PCa PROMs Study aims to give a voice to underrepresented groups and create a more fair and inclusive approach to prostate cancer research and care.

• We want to identify shortcomings in accessibility to information and care.
• We want to understand the unique challenges these men face by looking at how social, economic, and healthcare issues affect diagnosis, treatment, and overall quality of life.
• We want to make real change by using the findings to improve healthcare services and access to information, change policies, and improve clinical guidelines to better serve these men.

The Diversity in PCa PROMs Study can help Black men and men of mixed ethnic ancestry in several important ways:

1. Giving them a voice:
   By including their experiences, the study makes sure these men are seen and heard. It helps show their needs and challenges, making their voices stronger in healthcare and research discussions.
2. Improving healthcare access:
   The study can point out where healthcare is lacking and push for better access to screenings, treatments, and support. This helps ensure these men get the care they need when they need it.
3. Tailoring treatments to their needs:
   By understanding how prostate cancer affects these men differently, healthcare providers can create more personalised treatment plans. This means Black men and men of mixed ethnic ancestry are more likely to get the care suited to their unique needs.
4. Raising awareness and education:
   As the study highlights the higher risks for Black men and men of mixed ethnic ancestry, it helps raise awareness in both the medical community and within these communities themselves. More knowledge can lead to earlier detection, better outcomes, and better-informed health decisions.
5. Influencing policy and guidelines:
   The findings of this study can help change healthcare policies and clinical guidelines to address the specific needs of Black men and men of mixed ethnic ancestry. This could lead to more supportive healthcare programmes and better research focused on improving their outcomes.
6. Building community support:
   The study can help create stronger connections between these men, patient groups, and healthcare providers. It can help create awareness and build a sense of community. It can help empower them to take control of their health and speak up for themselves.

Overall, the study helps men of Black African/Black African-Caribbean ancestry and men of mixed ethnic ancestry by providing the tools, information, and support they need to manage prostate cancer better and improve their healthcare. 

Many different charities and patient support groups in Brazil, Sierra Leone, Suriname, the United Kingdom, and the United States are actively supporting this study.

Here’s a list of our partners:

• Cancer Black Care (CBC), UK
• CanSurvive UK, UK
• Cancer Don't Let It Win (CDLIW), UK
• Cancer UK Salone, UK and Sierra Leone
• Errol McKellar Foundation, UK
• Friends of Caswell Thompson (FOCT), UK
• Latin American Cooperative Oncology Group (LACOG), Brazil
• ORCHID, UK
• Prostate Cancer Foundation Suriname, Suriname
• Prostate Cancer UK (PCUK), UK
• Prostate Cancer Research (PCR), UK
• Rose Thompson Foundation, UK
• Tackle Prostate Cancer, UK
• The Institute of Cancer Research (ICR), London, and Royal Marsden NHS Foundation Trust, UK
• ZERO Cancer, USA

This study is run by a dedicated team. Here’s a bit about who they are and what they do.

Professor Eamonn Rogers
Eamonn is a Consultant Urologist at Bon Secours Hospital in Galway. As Chairman of the European Association of Urology Patient Office, he is in charge of this project.

Denzil James
Denzil is a Research Programme manager in the Oncogenetics Team at The Institute of Cancer Research, London, and Royal Marsden NHS Foundation Trust. As the Programme Manager, he is responsible for managing the project, formulating the findings and recommendations, and preparing the final report.

Esther Robijn
Esther is the Senior Coordinator at the European Association of Urology Patient Office. She helps manage the day-to-day work related to this study.

Dr. Natalia Norori
Natalia is the Senior Data & Evidence Manager at Prostate Cancer UK. Her team will support Denzil with the collection and analysis of the data.

Dr. Harris Wong
Harris is a Health Data Analyst at Prostate Cancer UK. He will support Denzil with the collection and analysis of the data.

Dr. Lukas Kurz
Lukas is a urologist at Charité – Universitätsmedizin Berlin in Germany. Lukas will assist Denzil with formulating the findings and recommendations and preparing the final report.

Dr. Márk Horváth
Márk is a urologist at Petz Aladar Hospital, Gyor in Hungary. Márk will assist Denzil with formulating the findings and recommendations and preparing the final report.

Dr. Eva McGrowder
Eva is a Senior Trial Manager in the Oncogenetics Team at The Institute of Cancer Research, London, and Royal Marsden NHS Foundation Trust. She is a strong advocate for Black men with prostate cancer and has worked closely with the Black community to raise awareness about the disease and the challenges they face. Eva also helps keep communication flowing between the Patient Office and the study’s stakeholders.

Rob Cornes
Rob is a male cancer nurse specialist and works for Orchid, a UK Charity that is dedicated to supporting anyone affected by prostate, testicular or penile cancer. Rob is a member of the EAU Patient Advocacy Group (EPAG) and eUROGEN and a patient advocate on the EAU Testicular Guidelines Panel.

If you have any questions about the study, feel free to contact us at info@patientinformation.org.

If you need help filling out the questionnaire, please contact your local charity. You can find their contact details below.

Who can take part in this study?

• You can take part if you are 18 years old or older.
• This is an online questionnaire, so you’ll need a phone, tablet, or computer with internet access.
• Before you join, you’ll be asked to give informed consent.

What does “informed consent” mean?

Informed consent means you understand what the study is about and what you’re agreeing to do.

You likely heard about this study through one of our partners, which means you’re eligible to take part. Or, you might be a partner, family member, or friend of someone with prostate cancer — you’re very welcome to complete the questionnaire together with them or on their behalf.

To participate, simply click the link or scan the QR code provided.

If you come across any wording or phrases in the questionnaire that are unclear, you can use the following link for further explanations and helpful definitions. This resource is designed to support your understanding and make the survey as straightforward as possible.

Do you need assistance?

If you need any assistance completing the questionnaire, please don’t hesitate to reach out. Our partners are here to support you and can be contacted at any time. You’ll find their contact details listed below.

Cancer UK - Salone

Cancer UK - Salone is a charity based in the UK that helps people with cancer who are struggling, both in the UK and in Sierra Leone. They focus on supporting patients from underserved and ethnic minority communities by offering care that respects each person’s dignity and needs. 

Their services include emotional support, counselling, food for those in need, help for carers, and community outreach to make sure people can get to appointments and pick up medicine. In Sierra Leone, they run the country’s first big campaign to raise awareness about prostate cancer, encouraging men to get tested early and educating communities. In the UK, they work with other groups to support Black men, who are more at risk of prostate cancer, through local events and campaigns. The charity works closely with health workers and community partners and makes sure its volunteers are trained and safe to work with vulnerable people. Their goal is to make cancer care fairer, more accessible, and better for everyone.

If you'd like to get in touch with Cancer UK Salone, contact Tina Davies by phoning +44 07949401836 (UK) +232 79623439 / +232 80623623 (Sierra Leone). Email: tdavies@canceruksalone.com, info@canceruksalne.org 

"When it comes to prostate cancer, silence kills — but support heals. For Black African men, early detection, equal access and community-based care are not just needs, they are rights. At Cancer UK-Salone, we stand firmly in the gap—ensuring that no brother walks this journey alone." - Cancer UK - Salone